ALVO - Alvotech SA Quarterly EPS earnings growth
Stable demand for biosimilars with long life cycles provides Alvotech (ALVO) with steady revenue, as confirmed by the quarterly EPS gap; the -275.40 level captures the current state of the metric. The company's profitability is based on a discount strategy relative to original drugs. FDA approvals and the launch of affordable versions of blockbusters in the US market create the potential for a sharp surge.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_ALVO_-_Alvotech_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "alvotech.com (ALVO): Year-over-year earnings per share growth for the last twelve months from 04/28/2023 to 11/11/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Alvotech Biopharmaceuticals (ALVO)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
ALVO - Company Net Income|Projected Future Earnings Alvotech|ALVO - Price to Earnings Ratio|Forward P/E Multiple Alvotech Corp|ALVO - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Alvotech Corp|ALVO - Operating profit EBITDA|Earnings per share for the last twelve months Alvotech|ALVO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months alvotech.com|ALVO - Earnings per share growth in current year|Net earnings per share growth forecast for next year Alvotech
Fundamental valuation:Alvotech
Alvotech is implementing high-tech bioreactor automation to scale the production of biosimilars. The quarterly EPS growth rate quantifies the efficiency of these investments through the dynamics of net profit per share. This indicator measures the growth rate of shareholder value while filtering out short-term volatility. Analysis of the curve allows for an assessment of the business's actual operating capacity. A steady upward trend confirms a successful transition to industrial-scale production.
Analysis of competing companies
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|Quarterly EPS earnings growth Liquidia Corp LQDA|GLPG - Year-over-year earnings per share growth for the last twelve months|ANIP: Year-over-year earnings per share growth for the last twelve months|MNKD (MannKind Corporation) - Year-over-year net earnings per share growth for the last 12 months|AMPH (amphastar.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Pacira BioSciences, Inc.|Earnings per share growth in annualized terms for the last twelve months ARS Pharmaceuticals Inc SPRY|Year-over-year net earnings per share growth for the last 12 months TBPH (Theravance)|Year-over-year earnings per share growth rate for the last twelve months AQST|Quarterly EPS earnings growth SCPH (scPharmaceuticals)|Tectonic Therapeutic Inc. (TECX) - Earnings per share growth in annualized terms for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Quarterly EPS earnings growth|China SXT Pharmaceuticals (SXTC) - Year-over-year net earnings per share growth for the last 12 months|EPRX: Quarterly EPS earnings growth|BioHarvest Sciences Inc - Year-over-year earnings per one share growth for the last 12 months|EXOZ (eXoZymes Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Oramed Pharma|Year-over-year earnings per share growth for the last twelve months Entera Bio Ltd. (ENTX)|Year-over-year earnings per share growth for the last twelve months HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma Inc - Year-over-year net earnings per share growth for the last 12 months|Cumberland Corp - Year-over-year earnings per share growth for the last twelve months|QNTM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months fibrogen.com|Telomir Pharmaceuticals, Inc. (TELO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months RANI (Rani Therapeutics Holdings, Inc.)|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|RLYB: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LEXX|Quarterly EPS earnings growth pulmatrix.com (PULM)|Year-over-year earnings per share growth for the last twelve months Pheton Holdings PTHL|Year-over-year earnings per one share growth for the last 12 months APM|LYRA - Year-over-year earnings per share growth for the last twelve months|impactbiomedinc.com (IBO) - Year-over-year net earnings per share growth for the last 12 months|TNFA: Quarterly EPS earnings growth|cbdMD (YCBD) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months PRFX|CYTO: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Lipella (LIPO)|OPTN - Earnings per share growth in annualized terms for the last twelve months|Pieris Pharmaceuticals - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months PROC (procapsgroup.com)|Petros Pharmaceuticals, Inc. - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months QLI (Qilian International Holding Group)|SLRN: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months TFF Pharmaceuticals, Inc (TFFP)
